Pages that link to "Q71775218"
Jump to navigation
Jump to search
The following pages link to Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis (Q71775218):
Displaying 50 items.
- Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients (Q24187385) (← links)
- Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients (Q24244091) (← links)
- Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study (Q33899996) (← links)
- Management of renal hyperparathyroidism (Q33983813) (← links)
- Endocrine abnormalities in chronic renal failure (Q34677226) (← links)
- New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure (Q35553304) (← links)
- An update on vitamin D as related to nephrology practice: 2003 (Q35553309) (← links)
- CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy (Q35825603) (← links)
- The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients (Q35848015) (← links)
- Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients (Q36166690) (← links)
- Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease (Q36227410) (← links)
- Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients (Q36677395) (← links)
- Correlates of parathyroid hormone concentration in hemodialysis patients (Q36936601) (← links)
- Mineral metabolic abnormalities and mortality in dialysis patients (Q36994038) (← links)
- Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis (Q37106569) (← links)
- Adynamic bone in patients with chronic kidney disease (Q37109205) (← links)
- Calcimimetics in chronic kidney disease: evidence, opportunities and challenges (Q37182739) (← links)
- Role of bone biopsy in stages 3 to 4 chronic kidney disease (Q37319136) (← links)
- Bone and kidney disease: diagnostic and therapeutic implications (Q37986588) (← links)
- Renale osteodystrophie (Q38105272) (← links)
- The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. (Q38836379) (← links)
- Noninvasive assessment of bone health in Indian patients with chronic kidney disease (Q42092498) (← links)
- Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function (Q42621248) (← links)
- Uremic osteoporosis (Q42727513) (← links)
- Prevention of secondary hyperparathyroidism in hemodialysis patients: The key role of native vitamin D supplementation (Q42855659) (← links)
- Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients (Q44423486) (← links)
- Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race (Q44544709) (← links)
- Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism (Q44647160) (← links)
- Determinants of progressive vascular calcification in haemodialysis patients (Q44854970) (← links)
- Total Parathyroidectomy with Forearm Autotransplantation as the Treatment of Choice for Secondary Hyperparathyroidism (Q46293140) (← links)
- Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe? (Q47150518) (← links)
- Calcium Homeostasis in Health and in Kidney Disease (Q48038085) (← links)
- Surgical treatment of renal hyperparathyroidism (Q51547314) (← links)
- Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis. (Q53669296) (← links)
- Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study. (Q53811045) (← links)
- Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort. (Q55436115) (← links)
- Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients. (Q55463750) (← links)
- Bone disease in long-term dialysis (Q71865072) (← links)
- Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis (Q74063884) (← links)
- Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients (Q77823315) (← links)
- Effect of haemodialysis on markers of bone turnover in children (Q79537591) (← links)
- New PTH assays and renal osteodystrophy (Q80152901) (← links)
- Predictors of bone mineral density in patients on hemodialysis (Q80335869) (← links)
- Parathyroid hormone assay: problems and opportunities (Q80490166) (← links)
- Is parathyroid hormone measurement useful for the diagnosis of renal bone disease? (Q80795092) (← links)
- Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta (Q81162180) (← links)
- [Evaluation of parathyroid function in presternal subcutaneous grafting after total parathyroidectomy for renal hyperparathyroidism] (Q81397863) (← links)
- Calcium and phosphate balance in adolescents on home nocturnal haemodialysis (Q83048367) (← links)
- Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients (Q83245882) (← links)
- Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease (Q83399687) (← links)